-
Melanoma Risk in Childhood Cancer SurvivorsPeople treated for childhood cancer found to have twice the risk of developing melanoma as an adult.
by Cameron Walker
-
Should All Kids With Cancer Get Genetic Testing?Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.
by Marcus A. Banks
-
A Drive for DiversityAfrican Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
Treating Cancer Patients With COVID-19: A New York City ExperienceAn analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
-
Life After Pediatric Brain CancerSurvivors of pediatric brain or spinal cord tumors can have cognitive and physical impairments. Researchers say that these deficits can be minimized with the right interventions.
by Cheryl Platzman Weinstock
-
Bill Aims to Improve Childhood Cancer ResearchThe STAR Act passes in the U.S. House of Representatives.
by Brad Jones
-
A Focus on Pediatric Cancer ScreeningThe AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.
by Garrett M. Brodeur
Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
